All In MedTech

FDA Clearance Tracker · P150012-S176

INGEVITY™ MRI tined and extendable/retractable fixation leads / INGEVITY+™ leads

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 20, 2026

Approved

Time to decision

80 days

Received Dec 2, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150012-S176
Device name
INGEVITY™ MRI tined and extendable/retractable fixation leads / INGEVITY+™ leads
Applicant location
St Paul, MN
Received
Dec 2, 2025
Decided
Feb 20, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150012

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

to transfer the 100% ethylene oxide (EO) gas sterilization process for the CRM leads from BSC's Dorado, Puerto Rico site to BSC's Coventry, Rhode Island site

Source documents

Other decisions for Boston Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.